Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1997-08-15
2000-01-11
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 854, 514 2, A61K 3821, A61K 3817
Patent
active
060132531
ABSTRACT:
The present invention encompasses methods for preventing and treating multiple sclerosis by administering to patients in need thereof a therapeutically effective amount of IFN-con in combination with IL-1ra.
REFERENCES:
patent: 4695623 (1987-09-01), Stabinsky
patent: 4897471 (1990-01-01), Stabinsky
patent: 5075222 (1991-12-01), Hannum
patent: 5372808 (1994-12-01), Blatt
patent: 5541293 (1996-07-01), Stabinsky
Dhib-Jalbut, S., et al., (1996) J. IFM Cytokine Res. 16: 195-200.
Martin, D., et al. (1995) J. Neuroimmunol. 61(2): 241-245.
Waksman, et al. Proc. Soc. Exp. Biol. Med. "Multiple Sclerosis as a Disease of Immune Regulation" 175:282-294 (1984).
Hafler, et al. Immunol. Rev., "T Cells in Multiple Sclerosis and Inflammatory Central Nervous System Diseases" 100:307-332 (1987).
Rosenberg, et al. "Principles and Applications of Biologic Therapy" in Cancer: Principles and Practices of Oncology, 3rd ed.
Balmer DICP, Ann Pharmacother "Clinical use of Biologic Response Modifiers in Cancer Treatment" 24: 761-768 (1990).
Ozes et al., J Interferon Research, "A Comparison of Interferon-Con 1 . . . " 12:55-59 (1992).
Klein et al., J. Chromatog. "Structural Characterization of Recombinant Consensus Interferon-.alpha." 454:205-215 (1988).
Fish et al., J. Interferon Res. "The Rode of Three Domains in the Biological Activity of Human Interferon-.alpha." 9:97-114 (1989).
Abreu et al., Immunol. Commun., "Suppression of Experimental Allergic Encephalomyelitis by Interferon" 11: 1-7 (1982).
Abreu et al., Int. Arch. Allergy Appl. Immunol., "Inhibition of Passive Localized Experimental Allergic Encephalomyelitis by Interferon" 72:30-33 (1983).
Johns et al., Journal Immunol. "Sucdessful Treatment of Experimental Allergic Encephalomyelitis with Transforming Growth Factor-.beta.11" 147:1792-1796 (1991).
Collins, U.S. Provisional Patent Application No. 60/011,419 (No copy attached).
Collins, et al., U.S. Provisional Patent Application No. 60/032,789 (No copy attached).
Fischer Norman L.
Martin David
Amgen Inc.
Crandall Craig A.
Fitzgerald David L.
Levy Ron K.
Odre Steven M.
LandOfFree
Treatment of multiple sclerosis using consensus interferon and I does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of multiple sclerosis using consensus interferon and I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis using consensus interferon and I will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459699